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We recently clonsd the IICWCSI humnn integrin p subunit, termed/?,. from a cDNA library construe& from SEA-aaivalcd T lymphocyks. In this 
communication, we report on the structure of the human integrin p, protein complex determined using a rabbit anti-/?, prqide antibody raised 
to an N-terminal 22 amino acid residue scqucncc deduced Don] the human ,0, subunit cDNA. The fi, subunh (M, I 16 000) expre5xd on PHA 
Iympboblas(s associates with a single major a subunit (a,,) that is dlstinfl from the prominent Tccll marker, intqrin a,. Their,, subunit (M, IS0 000 
nonreduccdj displays 3 distinctive shift in size on reduction to an apparent I%E, uf 150 000. We show rhat the5~ shuctural propertie of the integrin 
p, complex are shared with the cell surfxc antigen HML-I found highly expressed on T cells which populate the intestinal cpithelium and are 
proposed to be involved in rnucoslll immunity. Sequential immunoprccipitation and Western blotting demonstrate identity or close homology 
between the a,@, and HML-I proteins. 
Integrin; p, subunit; HML-I; Protein structure 
1. 1NTRODUCTION 
T lymphocyte activation in response to immunologic 
challenge is accompanied by a rapid transition between 
adherent and nonadherent states (reviewed in [I]). This 
results from an array of activation-dependent adhesion 
mechanisms involving an ensemble of adhesion recep- 
tors displayed on resting T lymphocytes. There follows 
an increase in surface expression of adhesion molecules 
including CD2 (Tl I), CD44 (Hermes) and the integrins, 
lymphocyte function-associated antigen-l (LFA-I), 
very late antigen (VLA)4, -5, -6, during the subsequent 
differentiation process [I]. This change in adhesive 
character may account for the preferred localisation of 
memory cells to mucosal surfaces and distinct lymphoid 
microenvironments, and may enhance the sensitivity of 
memory cells to antigens [l]. 
We have described the cloning of a novel activation- 
dependent integrin /? subunit with a presumed adhesive 
function, termed integrin &, from both human [2] and 
Ab/~ro~iuriu~s: USA. bovine serum albumin; IEL, inlracpithclidl lym- 
phocytes; LPAM-I. lymphocyte Peyer’s palch adhesion molecule-I; 
PDL. peripheral blood lymphocyte; PHA, phytohacma~lu~inin; 
VLA, very late antigen; VnR. vitronectin recuptor. 
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mouse lymphocytes [3]. The deduced N-terminal se- 
quence of the mouse ,8, subunit was found to be identi- 
cal to the N-terminus of the b subunit of the M290 
antigen, a surface molecule found highly expressed on 
mouse intestinal intraepithelial lymphocytes (IEL), and 
dn a majority of T cells in the gut lamina propria [33. 
The M290 antigen which is composed of multiple subu- 
nits (100 000-170 00 kDa [4] seems superficially simi- 
lar to other IEL surface differentiation markers identi- 
fied in rat (IO0 000-200 00 kDa) and humans 
(105 000-l 50 000 kDa) by the RGL-1 [T] and HML-I 
[6] mAbs. The curious constitutive xpression of these 
markers on IEL in the small intestine and their de novo 
inducibility on peripheral blood T cells following cell 
activation has drawn several suggestions for their func- 
tions. The M290 antigen is thought to perform an adhe- 
sive function which regulates effector cell activity during 
IEL defence of the mouse gut mucosa [4]. It was specu- 
lated that this antigen might be involved with lympho- 
cyte homing to cpithelial surfaces, but it was considered 
more likely that it was induced locally by inflammatory 
cytokines when lymphocytes actually reached the gut 
[4]. It was postulated that HML-I positive T lympho- 
cytes in the intestinal lamina propria represent a spccia- 
lised memory T cell subset since they express CD45R0, 
T rmll m.-lrlnr ‘out oa;y paitiatfy eXpiCS5 the iX?Z7%3;_~* a KI1 IaaubRCI 
CD29 173. HML-I was considered unlikely to represent 
a homing receptor since all lymphocyte subsets in gut- 
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associated lymphoid tissues use common migratory 
pathways, yet only 40% of lamina propria lymphocytes 
expressed HML-1, and there was no exclusive restric- 
tion in expression between T cell types [7]. Finally, 
HML-I and RGL-I may define ditTerentiation antigens 
expressed on a population of non-B lymphocytes be- 
longing to a common-mucosac associated lymphoid 
system [6]. 
The similar structures, cellular distributions, regula- 
tory properties and putative functions for the RGL-I. 
HML-I, and P,-related M290 antigens indicate that 
these 3 complexes are probably species homologues, but 
this has not been formally proven since the various 
antibodies reacting with these molecules do not react 
across species. Here we report for the frst time the 
characterisation of the human integrin & protein com- 
plex expressed on phytohaemaggiutinin (PHA) lympho- 
blasts and compare its structure and immunochemistry 
with that of the human IEL antigen. HML-I, 
2. MATERIALS AND METHODS 
The 8, synlhetic pcptide (amino acid sequence DAKIPSTGDA- 
TEWRNPHLSMLGCG) corresponding LO N-terminal umino acid 
residues 5-26 deduced from ihe human p7 cDNA [2] was kindly syn- 
thesized by the Immuncx Corp.. Se;i&. USA. The peptidc sequence 
was chosen on the basis of ils prcdiclcd immunogeniciiy [8] ;md bc- 
cause it forms part of an aminoterminal exicnsion that is unique 10 
the@, subunit [2]. An anchoring cysteine residue and a glycinc spacer 
were incorporated at the C-terminus. The pcptide was coupled to 
porcine rhyroglobulin using rrr-maleimidoenzoyl N-hydroxysucci- 
nimide ester (MBS) at a ratio of approxim3~ely IO0 molecules of 
pcplidc to I molcculc of carrier. 
Anlisurum was r&cd in a New Zealand While rabbit by priming 
with a mixture of I50 yg of pcptidc coupled to thyroglobulin and 500 
yg of fret pcptidc cmulsilied in Frcund’s complete adjuvani. and by 
subsequent injections using incomplc\c Frcund’s. Antibody was puri- 
fied by al’finity chromatography an Protein A-Sepharosr and coupled 
directly IO Scpharosc CL-4B beads (4 mg antibody per ml beads) by 
the method of Kumel et al. [9]. The control anti-human VLA4 mAb 
(B-5GlO) [IO] was a kind gift from Dr M. Hemler (Dan+Farber 
Cancer lnstilutc, Boston. MA). Mouse anti-human vilroncctin recep- 
tor (VnR) mAb (13C2) [I I] was generously provided by Dr M. Horton 
(Waumopoiesis Research Group. Imperial Cancer Research Fund, 
London. UK). Some of the HML-1 mAb used for immunoprecipila- 
lion was purchased from Immunoicch (distributed by Hacm Pty Ltd. 
Vicloria, Auslralia). Conirol antibodies wcrc similarly coupled 10 Sc- 
pharose CL-413. 
2.3. Pwpcrrrtriurr of’ PHA iyirpltohhs 
PBL were isolated from fresh haparinired venous blood of healthy 
donors by ccnlrifugairion on FicolCHypaquc density gradicnu (Phar- 
rnacia). Cells were washed in RPM1 1640 LO reduce platclcl contami- 
nation, and cultured for 3 days in RPMI I640 medium containing 
penicillin (50 U/ml). slreplomycin (50 ,@ml), 7.5% (v/v) r0etai calf 
serum (Gibco BRL. New Zealand) and 5 lug/ml PHA at 37°C in a 6% 
CO2 incubator. 
2.4. SurJucr ifxhtliotr ottd it~tfttttttt~~r~cipilu~~~ft 
PHA lymphoblasts were lab&d at the cell su&cc by lactoperoxi- 
dase-calulyzcd iodinalion essentially as described previously [l?] and 
solubiliscd far 45 min in I% (v/v) Nonidel P-40 in IO mM Tris-HCI 
buffer. pH 7.4. I50 mM sodium chloride containing 30 mM iodoacel- 
amide. 2 mM phcnylmethylsulphonyl fluoride. and I mg/ml bovine 
strum albumin. Immunoprccipiltltion WBS carried OUL usinyantibody- 
Scpharosc matrices and anulyxed by SDS-PAGE on 7.5% slab gels as 
described [ 131. Ldbcllrd prolrins wcrc dclcclud by aularadiography at 
-7OOC using Kodak XAR-5 lilm with imcnsifying screens (Cranex 
Lighming Plus). Appurcnt molecular weights wcrc calculated by rcfcr- 
encc to the mobilitics of the following proteins: myosin (200 kDu). 
P-giitactosidase (116 tiDd), phosphorylusc 0 (94 kDa) and bovine 
serum albumin (67 kDa). 
Immunoprecipilales were olccirophorcsed by SDS-PAGE on 7.5% 
slab gels and proteins rransferrcd cleclrophorctically for IX h at 30 V 
in ;I Tris-glycine.methanol buffer [l4] to nhrocellulosc (Schleicher and 
Schucll). Filters were blocked overnight at 4°C wilh 2% (w/v) bovine 
strum albumin (BSA), I% dried skim-milk powder, 0.05% Twecn 20 
and 0.02% sodium azidc in phosphate bull’crcd saline (PBS). Immuno- 
rcactivc proteins wcrc revealed by incubating the lillcr overnight at 
4°C wilh anti-&peptide rabbit antibody (32~gIn-d) in PBScontitininy 
2% (w/v) BSA and 0.02% sodium azidc. After w;ishing 3-times in PBS, 
0.05% Twccn 20. lhr filter was incubaled for I h with a I:100 dilution 
of biotinylatrd goal anti-rabbit IgG (Vector Lnboralorics Inc.) and 
washed as above. The tiltcr was Rnally incubated for I h v;ith uvidin- 
biotinyl;l\cd horse-radish pcroxidasc conjugate (Vcclor ltiboratorirs) 
and after washing wus visuuliscd with chloronaph\hol(O.3,uuy/ml) and 
hydrogen peroxide (0.03%) in SO n?M Tris-HCI, pH 7.6. 
3. RESULTS AND DISCUSSION 
The anti-&peptide rabbit antibody immunoprecipi- 
tated from surface-labelled PHA lymphoblnsts a pro- 
tein complex with characteristics that typify the a/3 het- 
erodimeric integrin receptors (Fig. I). Noncovalently 
associated high-molecular-weight components of I80 
and 1 I6 kDa, here designated the aH and p7 subunits 
respectively, were resolved under nonreducing condi- 
tions. In addition, two minor 170 and I50 kDa bands 
were consistently seen. When reduced, the all subunit 
shifted to I50 kDn. whereas there was negligible change 
in mobility of the,& subunit. The shift of the aH subunit 
on reduction is typical of many of the integrin ~1 sub- 
units which are composed of disulphide-linked heavy 
and light chains [l5]. Despite the dramatic shift, no 
labelled a light chain was resolved on a higher per- 
centage acrylamide gel, suggesting that the light chain 
may be primarily intracellular and not labelled (data not 
shown). In some experiments the a,, subunit exhibited 
a minor breakdown product at 95 kDa, and the p7 
subunit a product at 80 kDa (data not shown). 
As mentioned above, the mouse integrin ,& subunit 
shares N-terminal amino acid sequence identity with the 
p subunit of the M290 IEL antigen, which in turn bears 
a gross structural similarity to a human IEL antigen, 
termed HML- I. The HML- I antigen was immunopreci- 
pitated to directly compare its structural relationship 
with the a,&, protein complex. The pattern of bands 
obtained under both nonreducing and reducing condi- 
tions was identical to that observed with the anti-&- 
peptide antibody (Fig. 1). The distinctive pattern of the 
nonreduced a subunits displaying the major I80 kDa 
band and minor bands at I70 and I50 kDa which may 
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Fig. I. Comparison of the p, and HML-I protein complexes by SDS-PAGE anulysis. Cell lysutes of 1251-labclled PHA lymphoblasts were 
immunoprccipitated with (A) anti-,&peptidc antibody (lane I): HML-I mAb (lane 3); normal rabbit immunogiobulin negative control (lane 3); 
anti-VnRrr (lane 4); anti-VLAa, (lane 5); und (B) HML-I mAb (lane I); anti-&pcptidc untibody (lane 2). Immunoprecipitatcs were analysed on 
7.5% SDS-polyncrylamidc gels under reducing (A) and non-xtiucing (i3) conditions. The rclcvunt portionof the nonreducinggcl (B) has bucn shown 
to highlight the distinctive pattcrn of bands shared between the /3, and HML-I protein complexes. The minor a-related bands arc indicated by 
asterisks. The band ,200 kDa (Fig. I& lane 2) was sometimes observed in immunoprecipitatcs with normal rabbit immunoglobulin (data not 
shown). Molecular weights arc shown in the left hand margins in kDn. 
represent partially reduced forms is evidence rhat the 
HML-1 and &associated a chains are very similar or 
identical. Completely different profiles of radiolabelled 
proteins were precipitated with control antibodies. 
Anti-VnRa gave a& chain at 95 kDa and an a, chain 
at I30 kDa. The anti-VLA cc? profile was also different 
giving the reported I45 (a,) (faint), I30 Cp,) and 80 kDa 
(a subunit breakdown product) bands [IO]. In the 
mouse VLAa, associates with the alternative p, and fl,, 
subunits [ 16.171. The a@,, lymphocyte Peyer’s patch ad- 
hesion molecule- I (LPAM-I) complex is present on the 
surface of certain T lymphocytes and has a role in lym- 
phocyte homing to Peycr’s patches located in the tcrmi- 
nal ileum of the small intestine [17]. LPAM-1 has so far 
been detected on certain high endothelial venule (HEW- 
binding T cell lymohoma lines, mesenteric lymph node 
lymphocytes and most normal lymphocytes [ 16,171. 
Since the ‘integrin /$IM290 antigen is constitutively 
expressed in the small intestine it is not unreasonable to 
conclude that the /3, subunit is j?,. PHA lymphoblasts 
expressed moderate levels of the VLA a4 and /?, subu- 
nits, yet no a, suhunit bands were detectable in anti+?,- 
peptide precipitates. and vice versa the 8, subunit band 
was not detected in VLA a4 precipitates. We conclude 
1 2 3 4 5 
95 - 
Fig. 2. Immunologic relationship of the 8, and HML- I protein complexes. (A) Sequential immunoprecipitation study. PHA lymphoblasls wcrc 
radioiodinated, lysed, and immunoprecipitatcd 2 successive times with the HML-I mAb (lanes I and 2) and then tested with the anti-@,-peptidc 
antibody (lane 3). The origin&l lysate was also immunoprecipitated with the anti-&-peptide antibody (lane 4). lmmunoprccipitatcs were onnlysed 
on 7.5% SDS-polyacrylamidc gels under reducing conditions. The relevant portion of the autoradiogram is illustrztcti. Varintions in the proportions 
of the tespecti*,ic a and p subunits recovered as visualised in this experiment were often observed. Molecular weights are shown in the left marein 
in kDa. (Y) :mmunoblcttieg snslgsis of the HML-I ,B subunit. Immunoprecipitatcd MML-I (lanes 2 and 3) or VLA a& (lanes 4 and 5) from 
radioiodiniatcd PHA lymphoblasts were subjected to reducing SDS-PAGE and transferred to nitrocellulose. The lrsnsfcrred proteins were probed 
with the anti-p,-pcptidc untibody (lanes 2 and 5) or subjected to autoradiography (lanes 3 and 4). The molecular weights of marker proteins 
developed with 1ndi.u ink are shown in the left margin in kDa. Lane I is a negative control of the HML-I mAb preparation probed with the 
anti-/J,-peptidc antibody. 
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that the p, and /3,, subunits are either distinct pro!& 
entities, or that the association of VLAa, with ,5, in 
PHA lymphoblusts is very weak and easily disrupted. A 
third possibility is that p, Cp,,) can associate with either 
aHML-I or a,. but that association with aHML-I is 
preferred because the resulting complex may be inher- 
ently more stable. 
To further verify that the ,l3, subunit and HML-I 
antibodies were precipitating the same antigen. sequen- 
tial immunoprecipitation experiments were carried out. 
Prcclearing the lysate with the MML-I antibody rc- 
moved the labelled proteins reactive with the&-peptide 
antibody (Fig. 2). 
The experiments described above strongly indicate 
that the HML- I and P,-associated a chains are structur- 
ally related or identical. To explore an immunological 
relationship between a7 and the HML-1 ,0 subunit, we 
used immunoblotting. The anti-P,-peptide antibody 
reacted with the I I6-kDa p subunit band contained in 
an HML-I immunoprccipitate resolved by SDS-PAGE 
(Fig. 3). A sharp band at 100 kDa was also visualized 
and may represent an intracellular p subunit precursor 
form since this band was not 1~51-labellcd. Notably, 
none of the VLA., bands were visudlised with the anti-& 
antibody. Thus, the/3 subunits comprising HML-I and 
a& are immunologically related, 
In summary, an antibody raised against a peptide 
sequence deduced from the human p7 cDNA clone has 
facilitated the identification of the encoded protein 
product. Taken together, the immunological and struc- 
tural relatedness of the at& and HML-I components 
indicates that the respective protein complexes are 
probably identical. The observed relationships of both 
the mouse M290 and human HML-I antigens to the 
in:egrin ak&J7 complex is in accord with the suggestion 
that the M290 and HML-I IEL antigens are species 
hornologues. The ‘HML-l/a& receptor is the only 
integrin to be rapidly synthesized de novo on activation 
of resting lymphocytes reaching half maximal levels 
within 3 days. Thus, this receptor may perform a func- 
tional role on antigen-specific peripheral blood lym- 
phocytes which arrive at a site of inflammation within 
hours following activation. Now that the M290 and 
HML-I antigens have been shown to be closely similar 
or identical to the aJ7 intcgrin, it will be possible to 
devise specific experiments based on our knowledge of 
integrin function to explore the role of these activation 
antigens in the gut and their involvement in inflnm- 
matin. 
NOTE ADDED 1N PROOF 
After this communication was submitted for publica- 
tion, Kiishaw and Murant iIS] reported that in the 
mouse p, was present on most lymph node lymphocytes 
in association with 01~. rather than aM290. Stimulation 
of mouse lymph node T cells with a combination of 
anti-CD3 and TGF-P induced the expression of aM290 
which preferentially associated with the,&, subunit. Che- 
lation of divalent cations had little effect on the stability 
of aM290 /I,, whereas the a&, complex was cor,l&tdy 
dissociated, suggesting that the former complex may be 
thermodynamically more stable. The results of our own 
study which suggests preferential association of aHML- 
1 and /3, in human lymphoblasts are in accord with the 
above findings. Kilshaw and Murant [IS] refer to un- 
published work by K. Micklem et al. which indcpcnd- 
ently confirms our contention that the HML-l/? subunit 
and j3, are identical. This work provides evidence that 
the N-termini of ,l?, and I-lML-lp are identical. 
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Health Rcwrch Council 01’ New Zcoland, the Auckland Medical 
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